Citations 1
A phase II NCCTG/CALGB trial of imatinib (STI571) in patients (pts) with c-kit-expressing relapsed small cell lung cancer (SCLC)
Dy, Grace K. , Miller, Antonius A., Mandrekar, Sumithra J. , Aubry, Marie Christine, Langdon, Robert M., Jett, James R., Adjei, Alex A. , Schild, Steven E.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7048-7048
